İSTANBUL’UN ÖNDE GELEN HASTANELERİNDEN BİRİNDE GRUP B STREPTOKOK TARAMA VE KOLONİZASYON ORANLARI

Giriş: Gebelerde üçüncü trimesterde grup B streptokok (GBS) taraması ve kolonizasyon oranlarını belirlemek. Gereç ve Yöntem: Eylül 2020-Şubat 2021 tarihleri arasında Kadın Hastalıkları ve Doğum Kliniğimizde takip ve doğum yapan 485 kadından geriye dönük olarak veri toplanmıştır. GBS taraması (yapılmış veya yapılmamış), tarama zamanlaması, tarama sonuçları, intrapartum antibiyotik profilaksisi ve GBS pozitif annelerin yeni doğan bebeklerinin sonuçlar analiz edildi. Bulgular: 485 gebeden 223'i (%46.0) GBS için tarandı ve dokuzu (%4.0) pozitif bulundu. Pozitiflik oranları, postoperatif komplikasyon yaşayanlarda komplikasyon yaşamayanlara göre anlamlı olarak daha yüksekti (%28.6'ya karşı %3.2; P = 0.027). GBS pozitif annelerden doğan dokuz bebekten biri yenidoğan yoğun bakım ünitesine yatırıldı, ancak GBS tespit edilmedi. Bu dokuz bebek arasında APGAR skorları sekiz tanesinde 9/10 ve birinde 8/9 idi. Dokuz bebekten sadece birinde yenidoğanın geçici takipnesi izlendi. Sonuç: GBS taraması Türkiye'nin diğer bölgelerindeki hastanelerde rutin olarak yapılmamakta olup, büyük imkanlara sahip, sosyokültürel düzeyi yüksek hastalara hizmet veren kliniğimiz de bile GBS tarama oranı %46 gibi düşük bir seviyede kalmıştır. GBS enfeksiyonu maternal ve neonatal mortalite ve morbidite açısından oldukça önemlidir ve kolaylıkla önlenebilir; bu nedenle gebelerin takibinde 35-37. haftalarda rutin tarama programına dahil edilmesi önemlidir.

GROUP B STREPTOCOCCI SCREENING AND COLONIZATION RATES IN ONE OF THE MAJOR HOSPITALS OF METROPOLITAN ISTANBUL

Introduction: To determine group B streptococci (GBS) screening and colonization rates in the third trimester in pregnant women. Materials and Methods: Data were collected retrospectively from 486 women who were followed up and delivered in our Obstetrics and Gynecology Clinic between September 2020 and February 2021. GBS screening (performed or not), screening timing, screening results, intrapartum antibiotic prophylaxis, and outcomes of babies born to GBS-positive mothers were analyzed. Results: Among 485 pregnant women, 223 (46.0%) were screened for GBS and nine (4.0%) were found to be positive. The positivity rates were significantly higher in those who experienced postoperative complications than those who did not experience complications (28.6% vs 3.2%; P = 0.027). One of the nine babies born to GBSpositive mothers was admitted to the neonatal intensive care unit, but GBS was not detected. Among these nine babies, the APGAR scores were 9/10 in eight and 8/9 in one. One of the nine babies had transient tachypnea of the newborn. Conclusion: GBS screening is not routinely performed in hospitals in other parts of Turkey and the GBS screening rate was as low as 46% in our advanced hospital, which serves patients of a high sociocultural level in a metropolitan city with the highest level of facilities. GBS infection is important in terms of maternal and neonatal mortality and morbidity and can be easily prevented; therefore, it should be included in the routine screening program at 35–37 weeks in the follow-up of pregnant women.

PDF

___

1. Zhu Y, Huang J, Lin XZ, Chen C. Group B Streptococcus colonization in late pregnancy and invasive infection in neonates in china: a population-based 3-year study. Neonatology 2019; 115(4): 301-9.
2. Chaudhary M, Rench MA, Baker CJ, Singh P, Hans C, Edwards MS. Group B Streptococcal colonization among pregnant women in Delhi, India. Pediatr Infect Dis J 2017; 36(7): 665-9.
3. Chen J, Fu J, Du W, Liu X, Rongkavilit C, Huang X et al. Group B streptococcal colonization in mothers and infants in western China: prevalences and risk factors. BMC Infect Dis 2018; 18(1): 291-8.
4. Jisuvei SC, Osoti A, Njeri MA. Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; a cross-sectional study. BMC Infect Dis 2020; 20(1): 302-10.
5. Winn HN. Group B streptococcus infection in pregnancy. Clin Perinatol 2007; 34(3): 387-92.
6. Gül HC, Dede M, Avcı İY, Eyigün CP, Pahsa A. Üçüncü Trimestr hamilelerde vaginal grup b streptokok kolonizasyonu. Klimik Dergisi 2005; 18(1): 27–9.
7. Caglayan M, Yetkin Yıldırım G, Koroglu N, Yıldırım G. Comparison of diabetic and non-diabetic term pregnant women in terms of Group B Streptoccus Carriage. Istanbul Med J 2018; 19(3): 263-7.
8. Yeh CC, Tsui KH, Wang PH. Group B streptococci screening. J Chin Med Assoc 2016; 79(3): 103-4.
9. Marió MJ, Valenzuela I, Vásquez AE, Illanes SE. Prevention of early-onset neonatal group B Streptococcal Disease. Rev Obstet Gynecol 2013; 6(2): 63-8.
10. ACOG Committee Opinion No. 279: Prevention of early-onset Group B Streptococcal disease in Newborns, Obstetrics & Gynecology 2002; 100(6): 1405-12
11. Cho CY, Tang YH, Chen YH, Wang SY, Yang YH, Wang TH, et al. Group B Streptococcal infection in neonates and colonization in pregnant women: An epidemiological retrospective analysis. J Microbiol Immunol Infect 2019; 52(2): 265-72.
12. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990; 162(3): 672-7.
13. Bidgani S, Navidifar T, Najafian M, Amin M. Comparison of group B streptococci colonization in vaginal and rectal specimens by culture method and polymerase chain reaction technique. J Chin Med Assoc 2016; 79(3): 141-5.
14. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-- revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59(RR-10): 1-36.